Pharmacogenomics of lung cancer: with a view to address EGFR-targeted therapies

Author： Joshi Victoria A   Kucherlapati Raju  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.8, Iss.9, 2007-09, pp. : 1211-1220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

EGFR-targeted therapies in lung cancer: predictors of response and toxicity

By Heist Rebecca Suk   Christiani David  

Pharmacogenomics, Vol. 10, Iss. 1, 2009-01 ,pp. : 59-68

Future Medicine

Access to resources Recommend Favorite

Targeted Therapies in Lung Cancer

By  

Current Pharmaceutical Design, Vol. 15, Iss. 2, 2009-01 ,pp. : 188-206

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted therapies in small-cell lung cancer

By Fernainy Khaled   Saba Nabil  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 8, 2007-08 ,pp. : 1033-1041

Informa Healthcare

Access to resources Recommend Favorite

Targeted Therapies for Non-Small Cell Lung Cancer

By  

Current Pharmaceutical Design, Vol. 13, Iss. 27, 2007-09 ,pp. : 2810-2831

Bentham Science Publishers

Access to resources Recommend Favorite

Molecularly-targeted therapies for non-small cell lung cancer

By Ramalingam Suresh   Belani Chandra P  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2667-2679

Informa Healthcare

Access to resources Recommend Favorite